SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-051560
Filing Date
2008-08-11
Accepted
2008-08-11 07:48:19
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-19066_110q.htm 10-Q 526456
2 EX-31.1 a08-19066_1ex31d1.htm EX-31.1 13899
3 EX-31.2 a08-19066_1ex31d2.htm EX-31.2 14329
4 EX-32.1 a08-19066_1ex32d1.htm EX-32.1 5626
5 EX-32.2 a08-19066_1ex32d2.htm EX-32.2 6537
  Complete submission text file 0001104659-08-051560.txt   568392
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 081004307
SIC: 2834 Pharmaceutical Preparations